Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial Academic Article uri icon

Overview

MeSH Major

  • Prostatectomy
  • Prostatic Neoplasms

abstract

  • Our model suggests that it is hard to justify surgery in patients with Gleason 6, T1 disease or in those patients much above 70 yr of age. Conversely, surgery seems unequivocally of benefit for patients who have Gleason 8, or Gleason 7, stage T2. For patients with Gleason 6 T2 and Gleason 7 T1, treatment is more of a judgment call, depending on patient preference and other clinical findings, such as the number of positive biopsy cores and comorbidities.

publication date

  • August 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3389180

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2012.04.024

PubMed ID

  • 22541389

Additional Document Info

start page

  • 204

end page

  • 9

volume

  • 62

number

  • 2